Bausch Lomb Inc Product Pipeline Analysis, 2018 Update [Report Updated: 15052018] Prices from USD $750

16:09 EDT 4 Aug 2018 | BioPortfolio Reports

Summary


Bausch Lomb Inc Bausch Lomb, a subsidiary of Valeant Pharmaceuticals International Inc, is a visioncare company with focus on the protection, enhancement and restoration of eyesight. It offers overthecounter supplements, eye care products, contact lenses, ophthalmic pharmaceuticals, lens care products, ophthalmic surgical devices and instruments. The company develops, manufactures and markets eye health products for the treatment of a wide range of eye conditions such as glaucoma, conjunctivitis, eye allergies, dry eye and retinal diseases. It has operations across the Americas, Europe, the Middle East, Africa and AsiaPacific. Bausch Lomb is headquartered in Bridgewater, New Jersey, the US.


This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.


The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.


Scope:


The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company Bausch Lomb Inc

The report provides pipeline analysis on all pipeline products of the company by equipment type, by indication, by development stage, and by trial status

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indications, applications and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials wherever applicable with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.


Reasons to Buy:


Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research Development strategies

Develop marketentry and market expansion strategies

Exploit inlicensing and outlicensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next highvalue products that your competitor would add in its portfolio


Note: Some sections may be missing if data is unavailable for the company

More From BioPortfolio on "Bausch Lomb Inc Product Pipeline Analysis, 2018 Update [Report Updated: 15052018] Prices from USD $750"